Results of the summarizing process for the arXiv paper: 2304.02587v1

Atherosclerosis is a chronic inflammatory cardiovascular disease that occurs when fatty plaque builds up inside an artery wall. The early stages of atherosclerotic plaque development are characterised by the presence of inflammatory tissues primarily consisting of foam cells and macrophages. In this study, authors Abdush Salam Pramanik, Bibaswan Dey, and G.P. Raja Sekhar present a multiphase model that explores the role of cytokines and oxidised low-density lipoprotein (oxLDL) in monocyte recruitment and foam cell production during early plaque growth. The study highlights how oxLDL creates a toxic environment towards macrophages and foam cells which can lead to their death beyond a threshold limit due to excessive consumption. Interestingly, the authors found that initially the plaque evolves rapidly but subsequently slows down due to oxLDL-induced toxicity. Additionally, they observed that the saturation of inflammatory cell volume fraction becomes independent of oxLDL concentration beyond the threshold limit referred to as the oxLDL toxicity limit. The findings suggest that a higher flux of oxLDL leads to decay in plaque growth while an increase in cytokine flux is favourable for enhanced plaque growth. The detailed analysis presented in this article provides critical insights into various biochemical and cellular mechanisms behind early plaque development. Overall, this two-phase model sheds light on how cytokines and oxidised LDL contribute to early-stage atherosclerotic plaque development and provides valuable information for developing effective treatments for this chronic disease.

• - Atherosclerosis is a chronic inflammatory cardiovascular disease caused by fatty plaque buildup in artery walls
• - Early stages of plaque development involve inflammatory tissues consisting of foam cells and macrophages
• - Study explores the role of cytokines and oxidised low-density lipoprotein (oxLDL) in monocyte recruitment and foam cell production during early plaque growth
• - oxLDL creates a toxic environment towards macrophages and foam cells, leading to their death beyond a threshold limit due to excessive consumption
• - Plaque growth initially evolves rapidly but subsequently slows down due to oxLDL-induced toxicity
• - Inflammatory cell volume fraction saturation becomes independent of oxLDL concentration beyond the threshold limit referred to as the oxLDL toxicity limit
• - Higher flux of oxLDL leads to decay in plaque growth while an increase in cytokine flux is favourable for enhanced plaque growth
• - Detailed analysis sheds light on various biochemical and cellular mechanisms behind early plaque development
• - Provides valuable information for developing effective treatments for atherosclerosis.

Atherosclerosis is a sickness that happens when fat builds up in the walls of our blood vessels. This can cause problems with how our heart works. When the fat first starts building up, it causes inflammation and cells called foam cells and macrophages show up to help. But too much of this fat (called oxLDL) can be toxic and kill these helpful cells. As time goes on, the growth of this fat slows down but we need to keep studying it so we can find ways to treat it better.

Atherosclerosis: Exploring the Role of Cytokines and Oxidised Low-Density Lipoprotein (oxLDL) in Early Plaque Development

Atherosclerosis is a chronic inflammatory cardiovascular disease that occurs when fatty plaque builds up inside an artery wall. The early stages of atherosclerotic plaque development are characterised by the presence of inflammatory tissues primarily consisting of foam cells and macrophages. In this study, authors Abdush Salam Pramanik, Bibaswan Dey, and G.P. Raja Sekhar present a multiphase model that explores the role of cytokines and oxidised low-density lipoprotein (oxLDL) in monocyte recruitment and foam cell production during early plaque growth.

The Role of oxLDL

The authors found that initially the plaque evolves rapidly but subsequently slows down due to oxLDL-induced toxicity. OxLDL creates a toxic environment towards macrophages and foam cells which can lead to their death beyond a threshold limit due to excessive consumption. Additionally, they observed that the saturation of inflammatory cell volume fraction becomes independent of oxLDL concentration beyond the threshold limit referred to as the oxLDL toxicity limit.

The Role of Cytokines

The findings suggest that a higher flux of oxLDL leads to decay in plaque growth while an increase in cytokine flux is favourable for enhanced plaque growth. This two-phase model sheds light on how cytokines and oxidised LDL contribute to early-stage atherosclerotic plaque development and provides valuable information for developing effective treatments for this chronic disease.

Conclusion

This detailed analysis presented in this article provides critical insights into various biochemical and cellular mechanisms behind early plaque development. By understanding these underlying processes, researchers can develop more targeted treatments for atherosclerosis with fewer side effects than current therapies offer today.